Determining SARS-CoV-2 non-infectivity state–A brief overview

dc.contributor.authorBrynjolfsson, Siggeir F.
dc.contributor.authorSigurgrimsdottir, Hildur
dc.contributor.authorGudlaugsson, Olafur
dc.contributor.authorKristjansson, Mar
dc.contributor.authorKristinsson, Karl G.
dc.contributor.authorLudviksson, Bjorn R.
dc.contributor.departmentFaculty of Medicine
dc.date.accessioned2025-11-20T08:55:30Z
dc.date.available2025-11-20T08:55:30Z
dc.date.issued2022-08-12
dc.descriptionPublisher Copyright: Copyright © 2022 Brynjolfsson, Sigurgrimsdottir, Gudlaugsson, Kristjansson, Kristinsson and Ludviksson.en
dc.description.abstractFrom the beginning of the COVID-19 pandemic, it has claimed over 6 million lives, and globally the pandemic rages with detrimental consequences, with the emergence of new more infectious and possibly virulent variants. A clinical obstacle in this battle has been to determine when an infected individual has reached a non-infectious state. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can be transmitted under diverse circumstances, and various rules and regulations, along with different testing methods, have been applied in an attempt to confine the transmission. However, that has proven to be a difficult task. In this review, we take together recently published data on infectivity and transmission of SARS-CoV-2 and have combined it with the clinical experience that physicians in Iceland have accumulated from the pandemic. In addition, we suggest guidelines for determining when patients with COVID-19 reach a non-infectious state based on a combination of clinical experience, scientific data, and proficient use of available tests. This review has addressed some of the questions regarding contagiousness and immunity against SARS-CoV-2.en
dc.description.versionPeer revieweden
dc.format.extent375591
dc.format.extent934242
dc.identifier.citationBrynjolfsson, S F, Sigurgrimsdottir, H, Gudlaugsson, O, Kristjansson, M, Kristinsson, K G & Ludviksson, B R 2022, 'Determining SARS-CoV-2 non-infectivity state–A brief overview', Frontiers in Public Health, vol. 10, 934242, pp. 934242. https://doi.org/10.3389/fpubh.2022.934242en
dc.identifier.doi10.3389/fpubh.2022.934242
dc.identifier.issn2296-2565
dc.identifier.other65398210
dc.identifier.othere280007d-fcc1-4a24-a284-deb1ab0974db
dc.identifier.other85136782602
dc.identifier.other36033758
dc.identifier.urihttps://hdl.handle.net/20.500.11815/6882
dc.language.isoen
dc.relation.ispartofseriesFrontiers in Public Health; 10()en
dc.relation.urlhttps://www.scopus.com/pages/publications/85136782602en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectCOVID-19en
dc.subjectnon-infectious stateen
dc.subjectSARS-CoV-2en
dc.subjecttransmission of SARS-CoV-2en
dc.subjectviral testingen
dc.subjectPublic Health, Environmental and Occupational Healthen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.titleDetermining SARS-CoV-2 non-infectivity state–A brief overviewen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/systematicreviewen

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
fpubh_10_934242.pdf
Stærð:
366.79 KB
Snið:
Adobe Portable Document Format

Undirflokkur